Lineage Cell Therapeutics
LCTX
#8192
Rank
$0.16 B
Marketcap
$0.88
Share price
-3.07%
Change (1 day)
-12.38%
Change (1 year)

Market capitalization of Lineage Cell Therapeutics (LCTX)

Market cap: $0.16 Billion USD

As of November 2024 Lineage Cell Therapeutics has a market cap of $0.16 Billion USD. This makes Lineage Cell Therapeutics the world's 8192th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lineage Cell Therapeutics from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024$0.16 B-12.38%
2023$0.19 B-4.09%
2022$0.19 B-51.84%
2021$0.41 B56.44%
2020$0.26 B98%
2019$0.13 B14.86%
2018$0.11 B-57.44%
2017$0.27 B-26.48%
2016$0.37 B0.08%
2015$0.37 B27.05%
2014$0.29 B42.91%
2013$0.20 B31.67%
2012$0.15 B-46.89%
2011$0.29 B-21.73%
2010$0.37 B161.91%
2009$0.14 B238.15%
2008$42.11 M345.76%
2007$9.44 M57.94%
2006$5.98 M-13.62%
2005$6.92 M-74.25%
2004$26.89 M42.73%
2003$18.84 M-13.77%
2002$21.85 M-59.14%
2001$53.48 M-37.59%
2000$85.69 M-11.34%
1999$96.65 M-44.55%
1998$0.17 B-6.81%
1997$0.18 B109.2%
1996$89.41 M

End of Day market cap according to different sources

On Nov 13th, 2024 the market cap of Lineage Cell Therapeutics was reported to be:

$0.17 Billion USD
by Nasdaq info icon info icon
$0.17 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$0.62 B 272.85%๐Ÿ‡บ๐Ÿ‡ธ USA